Welcome to Nivagen Pharmaceuticals

Meet Dr. Dixon

Nivagen Pharmaceuticals, Inc. is excited to announce the Launch of Calcium Gluconate Injection 100 mg/mL with First-To-Market 180-day Exclusivity!

This is a major milestone for our company as we are thrilled to Celiver on our promise of bringing quality medicines at affordable prices. We want to thank our partners for their commitment and trust in us.

Service

Growth through Global Partnerships

Product Development / Co-Development Model

Nivagen's business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products.

Acquisition & Licensing Model

The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments

Sales & Marketing

Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market.